Connecting the Mechanisms of Action to Patient Outcomes: Integrating the Latest Treatments for T2D Into Patient Care

Expert faculty review the mechanism of action of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists, and describe how knowledge of these actions can be used to guide treatment for patients with T2D and overweight or obesity.

Share

Program Content

Activities

Newer T2D Agents: A Quick Guide
GIP/GLP-1 Coagonists, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: A Quick Reference Guide
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2023

Activities

Connecting MoA to Physiology
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2023

Expires: November 14, 2024

Success With New T2D Medications
Strategies for Clinical Success With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Coagonists
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2023

Expires: November 06, 2024

Connecting MoA to Physiology
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Physiologic Actions
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2023

MoAs: SGLT2i, GLP-1 RAs, and GIP/GLP-1 RAs
Mechanisms of Action: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Receptor Coagonists
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 07, 2023

Incretin Commentary
Addressing the Buzz Around Incretin-Based Therapies With Patients
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 21, 2024

Expires: February 20, 2025

Activities

T2D Medications: Choosing the Right Patient
Choosing the Right Patient: Optimizing Success With Newer T2D Medications
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 15, 2023

Expires: November 14, 2024

Connecting MoA to Clinical Evidence
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Expires: December 04, 2024

Connecting MoA to Clinical Evidence
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Clinical Evidence
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Activities

T2D: Does Weight Loss Matter?
You and Type 2 Diabetes: Why Does Weight Loss Matter?
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 03, 2023

Connecting MoA to Patient Cases
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Patient Cases
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Expires: December 04, 2024

Late-Stage T2D Care
Patients With Late-Stage Type 2 Diabetes and Adjusting Current Regimens
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 28, 2023

Expires: November 27, 2024

Connecting MoA to Patient Cases
Integrating the Latest Treatments for T2D Into Patient Care: Connecting Mechanism of Action to Patient Cases
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2023

Activities

Incretin Therapies
Breaking Down the Headlines: Addressing the Buzz Around Incretin-Based Therapies With Patients
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with the Endocrine Society.

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner